Amlodipine/benazepril
Amlodipine/Benazepril

Amlodipine/benazepril is a combination medication used in the treatment of hypertension (high blood pressure). It combines two active ingredients: amlodipine, a calcium channel blocker, and benazepril, an angiotensin-converting enzyme inhibitor (ACE inhibitor). This combination is effective in lowering blood pressure by relaxing blood vessels and reducing the workload on the heart.
Medical Uses
Amlodipine/benazepril is primarily prescribed for the management of hypertension. By lowering blood pressure, it helps to prevent complications such as stroke, myocardial infarction, and kidney failure. The combination of a calcium channel blocker and an ACE inhibitor provides a synergistic effect, enhancing the antihypertensive efficacy compared to either agent alone.
Mechanism of Action
Amlodipine
Amlodipine is a dihydropyridine calcium channel blocker. It works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle. This action results in the relaxation of the smooth muscle in the arterial walls, leading to vasodilation and a subsequent decrease in blood pressure.
Benazepril

Benazepril is an ACE inhibitor. It functions by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing the levels of angiotensin II, benazepril decreases vasoconstriction and lowers blood pressure. Additionally, it reduces the secretion of aldosterone, which decreases sodium and water retention, further aiding in blood pressure reduction.
Side Effects
Common side effects of amlodipine/benazepril include dizziness, headache, cough, and edema (swelling). The cough is typically associated with the ACE inhibitor component, benazepril. Serious side effects may include angioedema, hyperkalemia, and renal impairment. Patients are advised to report any unusual symptoms to their healthcare provider.
Contraindications
Amlodipine/benazepril is contraindicated in patients with a history of angioedema related to previous ACE inhibitor therapy. It should not be used during pregnancy due to the risk of fetal harm. Patients with severe renal impairment or hepatic impairment should use this medication with caution.
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian